Publicaciones volver
Early neovascular bridging of choroidal neovascularization after ranibizumab treatment.
| Tipo: | Artículo |
| Autores: | Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J, Garcia-Feijoo J. |
| Títuto Revista: | Graefe's Archive for Clinical and Experimental Ophthalmology |
| Referencia: | |
| Centro: | 06 - UCM - IIORC |
Early neovascular bridging of choroidal neovascularization after ranibizumab treatment.
Source
Hospital Clínico Universitario San Carlos, Calle Profesor Martín Lagos s/n, Madrid, Spain. echejuan@yahoo.es
Abstract
BACKGROUND:
To report three cases of early choroidal neovascularization (CNV) bridging after ranibizumab treatment.
METHODS:
Three patients with two separated foci of CNV secondary to age-related macular degeneration (ARMD), pathologic myopia and multifocal choroiditis were treated with monthly injections of ranibizumab por a period of 3 months.
RESULTS:
All three cases showed early coalescence across the fovea of the two neovascular foci, already 1 month after the first ranibizumab injection. Best-corrected visual acuity (BCVA) decreased in the three cases more than 20 letters due to early foveal involvement.
CONCLUSIONS:
Two different foci of CNV show a great tendency to decrease patients' vision because of neovascular bridging with foveal implication.
- PMID: 19621235 [PubMed - indexed for MEDLINE]
